<unk>  is an antineoplastic agent that is FDA approved for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL)..   Common adverse reactions include nausea, fatigue, pyrexia, anemia, and vomiting, pneumonia, pyrexia, infection, anemia, increased creatinine, thrombocytopenia, and multi-organ failure..
Belinostat
Beraprost
Protriptyline
Levodopa
Beractant
Selegiline 
Pegvaliase
Valpromide